OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Exploring the therapeutic potential of ADC combination for triple-negative breast cancer
Linlin Lu, Zihe Niu, Zhujun Chao, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 12
Open Access | Times Cited: 9
Linlin Lu, Zihe Niu, Zhujun Chao, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 12
Open Access | Times Cited: 9
Showing 9 citing articles:
Small Molecule Therapeutics in the Pipeline Targeting for Triple-Negative Breast Cancer: Origin, Challenges, Opportunities, and Mechanisms of Action
Nneoma James, Esther Owusu, Gildardo Rivera, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6285-6285
Open Access | Times Cited: 5
Nneoma James, Esther Owusu, Gildardo Rivera, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6285-6285
Open Access | Times Cited: 5
Antibody-drug conjugate combinations in cancer treatment: clinical efficacy and clinical study perspectives
X. Shi, Kai Tang, Quanbin Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
X. Shi, Kai Tang, Quanbin Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Carbonic anhydrase IX-targeted SMDCs for cancer precision treatment
Haolin Zhang, K Feng, Guisen Li, et al.
Chinese Chemical Letters (2025), pp. 111047-111047
Closed Access
Haolin Zhang, K Feng, Guisen Li, et al.
Chinese Chemical Letters (2025), pp. 111047-111047
Closed Access
AIbZIP/CREB3L4 Promotes Cell Proliferation via the SKP2-p27 Axis in Luminal Androgen Receptor Subtype Triple-Negative Breast Cancer
Taichi Ito, Atsushi Saito, Yasunao Kamikawa, et al.
Molecular Cancer Research (2024) Vol. 22, Iss. 4, pp. 373-385
Open Access | Times Cited: 2
Taichi Ito, Atsushi Saito, Yasunao Kamikawa, et al.
Molecular Cancer Research (2024) Vol. 22, Iss. 4, pp. 373-385
Open Access | Times Cited: 2
Improving efficacy of TNBC immunotherapy: based on analysis and subtyping of immune microenvironment
Yalan Yang, Haifeng Li, Wei Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Yalan Yang, Haifeng Li, Wei Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Research on therapeutic clinical trials including immunotherapy in triple-negative breast cancer: a bibliometric analysis
Qi Xu, Xiaoyu Feng, Siyuan Qin, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Qi Xu, Xiaoyu Feng, Siyuan Qin, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Advancements in Clinical Research and Emerging Therapies for Triple-Negative Breast Cancer Treatment
Lili Xu, Pengtao Xu, Jingsong Wang, et al.
European Journal of Pharmacology (2024), pp. 177202-177202
Closed Access | Times Cited: 1
Lili Xu, Pengtao Xu, Jingsong Wang, et al.
European Journal of Pharmacology (2024), pp. 177202-177202
Closed Access | Times Cited: 1
Research on therapeutic clinical trials including immunotherapy in Triple- negative Breast cancer: A bibliometric analysis
Qi Xu, Xiaoyu Feng, Siyuan Qin, et al.
Research Square (Research Square) (2024)
Open Access
Qi Xu, Xiaoyu Feng, Siyuan Qin, et al.
Research Square (Research Square) (2024)
Open Access
Porous egg microparticles for controllable drug delivery and oncotherapy
Dan Yan, Wei Wang, ZhengZheng Xie
Precision Medical Sciences (2024)
Open Access
Dan Yan, Wei Wang, ZhengZheng Xie
Precision Medical Sciences (2024)
Open Access
